·1 хв читання · 77 слів·👁 6.8K↗ 3
Cuscaden waives walk-away right from SPH bid; gains final regulatory approval
The consortium also announced on Thursday night (Dec 2) that it has received the requisite regulatory approval from the Foreign Investment Review Board in Australia, which represents the final outstanding approval needed.
With all approvals received and the waiver of the MAE condition, the Cuscaden scheme "now delivers higher transaction certainty" compared to the Keppel scheme which still requires approval from Keppel's shareholders, its spokesperson said.
